Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

pill warning

Even Worse than Fentanyl

MP3 WAV

  • When a man died of a drug overdose in Colorado, it took time to figure out which drug. Because it wasn’t fentanyl but another opioid called nitazene. Even though nitazenes have been around for decades, they haven’t been widely used. But amid a raging opioid epidemic and a national crackdown on fentanyl, nitazenes may become more common.  

    Nitazenes were developed in the nineteen fifties and sixties and were meant to be a substitute for morphine. But they were so powerful that the FDA didn’t approve them. Now they’re a schedule one drug and illegal just like heroin and LSD. Nitazines are made in the lab and are inexpensive to produce. They block pain signals in the brain by binding to opioid receptors in the brain, spinal cord, and other sites in the body.  

    Depending on the chemical formulation, some nitazenes are 800 times more potent than morphine and 40 times more than even fentanyl!  They come in liquids, pills, and powder form. And just as illegal street drugs can be laced with fentanyl, they can also contain nitazenes without the user knowing. 

    According to the CDC, a record ninety-two thousand people died of drug overdoses in 2020 and nearly two-thirds were from synthetic opioids, mostly from fentanyl. 

    Up to 2,000 people may have died from nitazene since two thousand nineteen. The concern is that number will grow unless people are educated about the dangers they pose.   

    We are Drs. David Niesel and Norbert Herzog, at UTMB and Quinnipiac University, where biomedical discoveries shape the future of medicine.   For much more and our disclaimer go to medicaldiscoverynews.com or subscribe to our podcast. Sign up for expanded print episodes at www.illuminascicom.com or our podcasts at:  Medical Discovery News (buzzsprout.com) 

More Information

Old Drugs and New Challenges: A Narrative Review of Nitazenes
Nitazenes are a group of compounds developed in the 1950s as opioid analgesics, but they were never approved to market. As such, they are not well known outside of academic research laboratories. A characteristic of nitazenes is their high potency (e.g., hundreds to thousands fold more potent than morphine and other opioids and tenfold more potent than fentanyl). In the past few years, several nitazenes, including "designer analogs," have been detected in the illicit drug supply and have been implicated in overdose mortality, primarily due to their exceptionally high potency. 

Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021
The prevalence of nitazene deaths in the United States is unknown and the frequency of nitazene involvement in overdose deaths in Tennessee has not yet been assessed. However, of concern is that nitazenes are increasingly recorded in toxicology reports and death certificate cause-of-death fields. 

What are nitazenes?
What to know about the drug that can be 10 times as potent as fentanyl.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.